| Literature DB >> 34776364 |
Berna Hekimoğlu1, Filiz Aktürk Acar2.
Abstract
BACKGROUND: Corona Virus Disease 2019 (COVID-19) in pregnant women has important impacts on perinatal and neonatal outcomes. However, there are a limited number of studies investigating the effect of the pandemic period on newborns. With this study, we aimed to determine the impact of the 2020 COVID-19 outbreak on prenatal care, obstetric outcomes, neonatal mortality and morbidity.Entities:
Keywords: COVID-19; neonatal; neonatal morbidity; pandemic
Mesh:
Year: 2021 PMID: 34776364 PMCID: PMC8548836 DOI: 10.1016/j.pedneo.2021.08.019
Source DB: PubMed Journal: Pediatr Neonatol ISSN: 1875-9572 Impact factor: 2.586
Comparison of the groups in terms of maternal follow-up and complications.
| Studygroup (N:153) | Control group (N: 154) | P Value | |
|---|---|---|---|
| Maternalage (years) (mean ± SD) | 30.5 ± 5.2 | 30.9 ± 6.0 | 0.547 |
| Gravidity (mean ± SD) | 2.7 ± 1.4 | 2.6 ± 1.4 | 0.683 |
| Parity (mean ± SD) | 2.3 ± 1.2 | 2.1 ± 1.0 | 0.429 |
| The number of pregnant women visited to the obstetrics clinic within the last 30 days (n,%) | 89 (76.7%) | 111 (97.4%) | <0.001 |
| The pregnant women's last application time to the obstetrics clinic before delivery (days) | 25.1 ± 28.4 | 6.3 ± 6.8 | <0.001 |
| Premature rupture of membranes (n,%) | 5 (3.3%) | 2 (1.3%) | 0.448 |
| Maternal hypertension (n,%) | 20 (13.1%) | 19 (12.3) | 0.847 |
| Maternal diabetes (n,%) | 10 (6.5%) | 9 (5.8%) | 0.801 |
| 1 (0.7%) | 0 (0%) | 0.498 | |
| Entanglement of the umbilical cord (n,%) | 3 (2%) | – | 0.123 |
| Uterine rupture (n,%) | 1 (0.7%) | – | 0.498 |
| Placental abruption (n,%) | 2 (1.3%) | – | 0.248 |
| Presence of meconium in amniotic fluid (n,%) | 7 (4.6%) | 3 (1.9%) | 0.198 |
| Intrauterine fetal death (n,%) | 0 (0%) | 0 (0%) | – |
| Urgentevents in the emergency department | 13 (8.5%) | 3 (1.9%) | 0.010 |
Presentation in the second stage of labor, Cesarean section from the emergency room (uterine rupture, placental abruption, fetal distress etc.)
Comparison of the groups in terms of demographic characteristics, morbidity and mortality results of neonatal cases.
| Study group (N:153) | Control group (N: 154) | P Value | |
|---|---|---|---|
| Gestational age (weeks) (mean ± SD) | 36.7 ± 3.8 | 35.9 ± 3.2 | 0.003 |
| Prematüre delivery<28 gestational weeks (n,%) | 6 (3.9%) | 5 (3.2%) | 0.750 |
| Prematüre delivery <34 gestational weeks (n,%) | 27 (17.6%) | 27 (17.5%) | 0.979 |
| Prematüre delivery <37 gestational weeks (n,%) | 53 (34.6%) | 77 (50%) | 0.006 |
| Postdate delivery >40 gestational weeks (n,%) | 17 (11.1%) | 2 (1.3%) | <0.001 |
| Birth weight (g) (mean ± SD) | 2787 ± 879.1 | 2788.5 ± 856.32 | 0.989 |
| Gender (n,%) | 0.865 | ||
| Female | 78 (51%) | 80 (51.9%) | |
| Male | 75 (49%) | 74 (48.1%) | |
| Mode of delivery (n,%) | 0.309 | ||
| Spontaneous vaginal delivery (n,%) | 35 (22.9%) | 28 (18.2%) | |
| Cesarean delivery (n,%) | 118 (77.1%) | 126 (81.8%) | |
| Postnatal age (day) (mean ± SD) | 2.1 ± 4.5 | 2.6 ± 5.3 | 0.943 |
| Duration of hospitalization (day) (mean ± SD) | 14.0 ± 13.7 | 15.0 ± 19.5 | 0.590 |
| Small for gestational age (n,%) | 12 (7.8%) | 4 (2.6%) | 0.039 |
| 5.minutes Apgar score <7 (n,%) | 14 (9.2%) | 5 (3.2%) | 0.032 |
| Postnatal 1st hour ph < 7.1 (n,%) | 9 (5.9%) | 4 (2.6)%) | 0.153 |
| Respiratory distress requiring surfactan (n,%) | 30 (19.6%) | 40 (26%) | 0.184 |
| Total mechanical ventilator time (day) (mean ± SD) | 1.8 ± 4.1 | 1.4 ± 1.8 | 0.882 |
| Total non-invasive ventilation time (day) (mean ± SD) | 1.5 ± 2.3 | 2.1 ± 3.6 | 0.219 |
| Additional oxygen time (day) (mean ± SD) | 1.9 ± 3.4 | 3.5 ± 7.5 | 0.09 |
| PDA requiring medical treatment (n,%) | 5 (3.3%) | 4 (2.6%) | 0.750 |
| Necrotizing enterocolitis ≥ stage II, (n,%) | 7 (4.6%) | 2 (1.3%) | 0.103 |
| Pneumothorax (n,%) | 1 (0.7%) | 2 (%1.3%) | 1,00 |
| Hypothermia treatment (n,%) | 8 (5.2%) | 0 (0%) | 0.003 |
| Exchange therapy (n,%) | 1 (0.7%) | 0 (0%) | 0.498 |
| Mortality rate (n,%) | 7 (4.6%) | 2 (1.3%) | 0.104 |